(Q40752220)

23 September 2017

title

Troglitazone suppresses cell growth of KU812 cells independently of PPARgamma (English)

1 reference

23 September 2017

1 reference

Akihito Abe

1

1 reference

23 September 2017

Yoshimitsu Kiriyama

2

1 reference

23 September 2017

Masako Hirano

3

1 reference

23 September 2017

Toshiaki Miura

4

1 reference

23 September 2017

Hiroyuki Kamiya

5

1 reference

23 September 2017

Hideyoshi Harashima

6

1 reference

23 September 2017

Yukiko Tokumitsu

7

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

European Journal of Pharmacology

23 September 2017

published in

1 reference

23 September 2017

volume

436

1 reference

23 September 2017

issue

1-2

1 reference

23 September 2017

page(s)

7-13

1 reference

Inhibition of protein kinase C activity and vascular smooth muscle cell growth by d-alpha-tocopherol

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901577-1

Vitamin E: function and metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901577-1

PPARgamma activators down-regulate the expression of PPARgamma in 3T3-L1 adipocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901577-1

Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901577-1

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901577-1

The nuclear receptor PPAR gamma and immunoregulation: PPAR gamma mediates inhibition of helper T cell responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901577-1

Magnitude of peroxisome proliferator-activated receptor-gamma activation is associated with important and seemingly opposite biological responses in breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901577-1

Troglitazone induces expression of PPARgamma in liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901577-1

Basophilic differentiation of the human leukemia cell line KU812 upon treatment with interleukin-4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901577-1

The effects of thiazolidinediones on vascular smooth muscle cell activation by angiotensin II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901577-1

Troglitazone has a scavenging effect on reactive oxygen species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901577-1

Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901577-1

Roles of PPARs in health and disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901577-1

Histamine is a potent inducer of IL-18 and IFN-gamma in human peripheral blood mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901577-1

Mast cell-/basophil-specific transcriptional regulation of human L-histidine decarboxylase gene by CpG methylation in the promoter region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901577-1

36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901577-1

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901577-1

Differential expression of proteins regulating cell cycle progression in growth vs. differentiation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901577-1

Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901577-1

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901577-1

Molecular basis of vitamin E action. Tocotrienol potently inhibits glutamate-induced pp60(c-Src) kinase activation and death of HT4 neuronal cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901577-1

Troglitazone suppresses cell growth of myeloid leukemia cell lines by induction of p21WAF1/CIP1 cyclin-dependent kinase inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901577-1

Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901577-1

Peroxisome proliferator-activated receptor gamma ligands inhibit retinoblastoma phosphorylation and G1--> S transition in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901577-1

Troglitazone, an antidiabetic agent, inhibits cholesterol biosynthesis through a mechanism independent of peroxisome proliferator-activated receptor-gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901577-1

Mechanisms of action of troglitazone in the prevention of high glucose-induced migration and proliferation of cultured coronary smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901577-1

10.1016/S0014-2999(01)01577-1

7 January 2021

Identifiers

DOI

1 reference

23 September 2017

1 reference